New treatments

How private equity oversees the ethics of drug research

As private equity firms expand their footprint into the world of pharmaceuticals testing, many drug trials are now being vetted by companies with ties to the drugmakers, raising concerns about conflicts of interest and patient safety.

This content was published on Oct 7, 2025 Many drug trials are vetted by companies with ties to the drugmakers, raising concerns about conflicts of interest and patient safety.

Roche claims clinical success against breast cancer

New treatments

Roche claims success against breast cancer in phase III clinical trials

This content was published on Sep 22, 2025 Roche has achieved positive results from the phase III evERA study combining its experimental treatments giredestrant and everolimus against a specific form of breast cancer.

Drug pricing

How a clash with Roche exposed cracks in Swiss drug pricing system

This content was published on Sep 19, 2025 Switzerland’s new process to speed up patient access to the latest drugs hit its first major hurdle in a clash with Roche.

An implant that gives paralysed people back their taste for life

Healthcare innovation

Swiss doctors develop implant for spinal cord injury patients

This content was published on Sep 18, 2025 An implant developed as a result of research carried out in Switzerland considerably improves the living conditions of people with spinal cord injuries, say the doctors behind this innovation.

Healthcare innovation

How Novartis got ahead on ‘incredible’ cancer breakthrough

This content was published on Sep 2, 2025 The Swiss pharma group has become a pioneer in a new type of targeted radiotherapy.

Prevention

Reinsurer Swiss Re issues longevity drug guidelines

This content was published on Aug 11, 2025 Swiss Re introduces new longevity drug guidelines and updated risk tools for insurers.

Prevention

Swiss regulator approves updated Covid-19 vaccine

This content was published on Aug 11, 2025 Swissmedic approves Moderna’s updated COVID-19 vaccine for ages 12 and up.

Novartis: good results for Sjögren's syndrome remedy

New treatments

Novartis posts encouraging results for Sjögren’s syndrome therapy

This content was published on Aug 11, 2025 Novartis reports promising phase III results for its Sjögren’s syndrome therapy Ianalumab.

Alcon strengthens lens business with billion-euro takeover

Healthcare innovation

Alcon strengthens lens business with major US acquisition

This content was published on Aug 5, 2025 Geneva-based eye care group Alcon is set to acquire the US company Staar, a specialist in implantable lenses.

New treatments

Swiss inaction threatens global antibiotic development push

This content was published on Jul 8, 2025 Switzerland risks stalling global antibiotic innovation amid rising resistance.

New treatments

Popular Stories

Most Discussed

New treatments

More

How private equity oversees the ethics of drug research

More

Roche claims success against breast cancer in phase III clinical trials

More

How a clash with Roche exposed cracks in Swiss drug pricing system

More

Swiss doctors develop implant for spinal cord injury patients

More

How Novartis got ahead on ‘incredible’ cancer breakthrough

More

Reinsurer Swiss Re issues longevity drug guidelines

More

Swiss regulator approves updated Covid-19 vaccine

More

Novartis posts encouraging results for Sjögren’s syndrome therapy

More

Alcon strengthens lens business with major US acquisition

More

Swiss inaction threatens global antibiotic development push

Popular Stories

Most Discussed